Heartflow Inc (HTFL)

$29.42 +0.03 (0.10%)
Market Cap 2.53B
Revenue (ttm) 176.03M
Net Income (ttm) -116.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -66.35%
Debt to Equity Ratio 0.00
Volume 1,211,700
Avg Vol 1,328,432
Day's Range N/A - N/A
Shares Out 86.24M
Stochastic %K 54%
Beta N/A
Analysts Strong Sell
Price Target $37.67

Company Profile

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anat...

Industry: Health Information Services
Sector: Healthcare
Phone: 650 241 1221
Address:
331 E. Evelyn Avenue, Mountain View, United States
NetworkNewsWire
NetworkNewsWire May. 11 at 1:07 PM
The Future of Intoxication Detection May Be in Your Voice $MBIO.CN $MBQIF $HTFL $RXRX $TEM $BFLY https://ibn.fm/hAnhh
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 6 at 3:43 AM
$HTFL RSI: 52.97, MACD: 0.8781 Vol: 1.73, MA20: 29.75, MA50: 26.43 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday May. 4 at 6:55 PM
$HTFL Share Price: $28.87 Contract Selected: Oct 16, 2026 $30 Calls Buy Zone: $3.57 – $4.41 Target Zone: $6.78 – $8.29 Potential Upside: 79% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
FilingTracker
FilingTracker May. 1 at 1:12 PM
$HTFL Massive insider sale: https://www.sec.gov/Archives/edgar/data/1464521/000119312526198593/xslF345X06/ownership.xml
0 · Reply
Davy_Stockett
Davy_Stockett Apr. 16 at 6:38 PM
$HTFL
0 · Reply
Iggymed
Iggymed Apr. 14 at 3:47 PM
$HTFL lookin good
0 · Reply
Thr0winDarts
Thr0winDarts Mar. 30 at 2:06 PM
$HTFL this dog shit gonna reverse or what
0 · Reply
Thr0winDarts
Thr0winDarts Mar. 26 at 7:00 PM
$HTFL I bought this back at 26.60 today. It’s destined to get crushed again now. Already down a buck
1 · Reply
healthcareguru
healthcareguru Mar. 19 at 1:56 PM
$HTFL nonsense move…going back <$20…lots of PE secondaries coming after lackluster print and slowing growth ahead; insanity valuation.👎 $XLV $IHI $IWM
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 18 at 9:24 PM
$HTFL Q4 '25 Earnings Results & Recap Heartflow reported 2025 revenue of $176M, a 40% increase from 2024, driven by a 47% rise in revenue case volume, achieving a 77% gross margin and a $116.8M net loss.
0 · Reply
Latest News on HTFL
Heartflow initiated with an Outperform at William Blair

2026-05-04T10:26:10.000Z - 9 days ago

Heartflow initiated with an Outperform at William Blair

Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

Apr 23, 2026, 4:05 PM EDT - 19 days ago

Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

Heartflow files patent infringement lawsuit against Cleerly

2026-04-13T13:04:47.000Z - 4 weeks ago

Heartflow files patent infringement lawsuit against Cleerly

Heartflow Files Patent Infringement Lawsuit Against Cleerly

Apr 13, 2026, 8:30 AM EDT - 4 weeks ago

Heartflow Files Patent Infringement Lawsuit Against Cleerly

Heartflow price target lowered to $35 from $40 at JPMorgan

2026-03-19T11:52:57.000Z - 7 weeks ago

Heartflow price target lowered to $35 from $40 at JPMorgan

Heartflow price target raised to $43 from $40 at Canaccord

2026-03-19T10:47:04.000Z - 7 weeks ago

Heartflow price target raised to $43 from $40 at Canaccord

HeartFlow Earnings Call Transcript: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 7 weeks ago

HeartFlow Earnings Call Transcript: Q4 2025

Heartflow reports Q4 EPS (29c), consensus (16c)

2026-03-18T20:21:23.000Z - 7 weeks ago

Heartflow reports Q4 EPS (29c), consensus (16c)

Heartflow sees FY26 revenue $218M-$22M, consensus $212.94M

2026-03-18T20:20:18.000Z - 7 weeks ago

Heartflow sees FY26 revenue $218M-$22M, consensus $212.94M

Heartflow announces clinical evidence, landmark registry launch

2026-03-16T12:12:03.000Z - 2 months ago

Heartflow announces clinical evidence, landmark registry launch

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Mar 16, 2026, 8:00 AM EDT - 2 months ago

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

HeartFlow Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026

Mar 3, 2026, 1:45 PM EST - 2 months ago

HeartFlow Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026

Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Feb 18, 2026, 4:05 PM EST - 2 months ago

Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Feb 13, 2026, 4:21 PM EST - 3 months ago

Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Heartflow announces expansion of its GAMEFILM Registry

2026-02-12T13:10:42.000Z - 3 months ago

Heartflow announces expansion of its GAMEFILM Registry

Heartflow initiated with an Overweight at Wells Fargo

2026-01-28T10:20:29.000Z - 3 months ago

Heartflow initiated with an Overweight at Wells Fargo

HeartFlow Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 4:30 PM EST - 4 months ago

HeartFlow Transcript: 44th Annual J.P. Morgan Healthcare Conference

Heartflow announces Plaque Analysis covered by Aetna insurance plans

2026-01-06T13:16:03.000Z - 4 months ago

Heartflow announces Plaque Analysis covered by Aetna insurance plans

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.

Jan 6, 2026, 8:00 AM EST - 4 months ago

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.

Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026, 4:05 PM EST - 4 months ago

Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference

ACC, AHA publish scientific statements supporting Heartflow plaque analysis

2025-12-18T21:25:37.000Z - 5 months ago

ACC, AHA publish scientific statements supporting Heartflow plaque analysis

Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD

Dec 18, 2025, 4:05 PM EST - 5 months ago

Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD

Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease

Dec 11, 2025, 3:10 AM EST - 5 months ago

Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease

HeartFlow Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 3, 2025, 3:30 PM EST - 5 months ago

HeartFlow Transcript: Piper Sandler 37th Annual Healthcare Conference

Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 19, 2025, 4:33 PM EST - 6 months ago

Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference

Heartflow price target raised to $40 from $35 at Stifel

2025-11-13T13:00:53.000Z - 6 months ago

Heartflow price target raised to $40 from $35 at Stifel

Heartflow price target raised to $40 from $36 at JPMorgan

2025-11-13T12:31:53.000Z - 6 months ago

Heartflow price target raised to $40 from $36 at JPMorgan

Heartflow price target raised to $40 from $39 at Canaccord

2025-11-13T11:51:38.000Z - 6 months ago

Heartflow price target raised to $40 from $39 at Canaccord

Heartflow reports Q3 EPS (27c), consensus (24c)

2025-11-12T21:31:19.000Z - 6 months ago

Heartflow reports Q3 EPS (27c), consensus (24c)

Heartflow sees FY25 revenue view $173M-$173.5M, consensus $165.97M

2025-11-12T21:30:47.000Z - 6 months ago

Heartflow sees FY25 revenue view $173M-$173.5M, consensus $165.97M

HeartFlow Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 6 months ago

HeartFlow Earnings Call Transcript: Q3 2025

Heartflow Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 4:01 PM EST - 6 months ago

Heartflow Reports Third Quarter 2025 Financial Results

AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification

Nov 9, 2025, 1:30 PM EST - 6 months ago

AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification

Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025

Nov 3, 2025, 8:00 AM EST - 6 months ago

Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025

Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025

Oct 23, 2025, 4:05 PM EDT - 7 months ago

Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025

New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning

Oct 22, 2025, 8:00 AM EDT - 7 months ago

New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform

Sep 22, 2025, 4:05 PM EDT - 8 months ago

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform

HeartFlow Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 10, 2025, 9:15 AM EDT - 8 months ago

HeartFlow Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 27, 2025, 4:24 PM EDT - 9 months ago

Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Aug 11, 2025, 4:30 PM EDT - 9 months ago

Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Heartflow Stock Opens Nearly 50% Above IPO Price in Latest Hot Debut

Aug 8, 2025, 1:58 PM EDT - 9 months ago

Heartflow Stock Opens Nearly 50% Above IPO Price in Latest Hot Debut

Medtech firm Heartflow gains 47% in solid Nasdaq debut

Aug 8, 2025, 1:05 PM EDT - 9 months ago

Medtech firm Heartflow gains 47% in solid Nasdaq debut

Medtech firm Heartflow raises $316.7 million in US IPO

Aug 7, 2025, 8:54 PM EDT - 9 months ago

Medtech firm Heartflow raises $316.7 million in US IPO

Heartflow, Inc. Announces Pricing of Upsized Initial Public Offering

Aug 7, 2025, 8:27 PM EDT - 9 months ago

Heartflow, Inc. Announces Pricing of Upsized Initial Public Offering

Bain Capital-backed Heartflow targets $1.5 billion valuation in upsized US IPO

Aug 6, 2025, 7:57 AM EDT - 10 months ago

Bain Capital-backed Heartflow targets $1.5 billion valuation in upsized US IPO

Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation

Aug 6, 2025, 4:48 AM EDT - 10 months ago

Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation

Bain Capital-backed Heartflow eyes $1.3 billion valuation in US IPO

Aug 1, 2025, 8:16 AM EDT - 10 months ago

Bain Capital-backed Heartflow eyes $1.3 billion valuation in US IPO

Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide

Jul 22, 2025, 6:28 PM EDT - 10 months ago

Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide

NetworkNewsWire
NetworkNewsWire May. 11 at 1:07 PM
The Future of Intoxication Detection May Be in Your Voice $MBIO.CN $MBQIF $HTFL $RXRX $TEM $BFLY https://ibn.fm/hAnhh
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 6 at 3:43 AM
$HTFL RSI: 52.97, MACD: 0.8781 Vol: 1.73, MA20: 29.75, MA50: 26.43 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday May. 4 at 6:55 PM
$HTFL Share Price: $28.87 Contract Selected: Oct 16, 2026 $30 Calls Buy Zone: $3.57 – $4.41 Target Zone: $6.78 – $8.29 Potential Upside: 79% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
FilingTracker
FilingTracker May. 1 at 1:12 PM
$HTFL Massive insider sale: https://www.sec.gov/Archives/edgar/data/1464521/000119312526198593/xslF345X06/ownership.xml
0 · Reply
Davy_Stockett
Davy_Stockett Apr. 16 at 6:38 PM
$HTFL
0 · Reply
Iggymed
Iggymed Apr. 14 at 3:47 PM
$HTFL lookin good
0 · Reply
Thr0winDarts
Thr0winDarts Mar. 30 at 2:06 PM
$HTFL this dog shit gonna reverse or what
0 · Reply
Thr0winDarts
Thr0winDarts Mar. 26 at 7:00 PM
$HTFL I bought this back at 26.60 today. It’s destined to get crushed again now. Already down a buck
1 · Reply
healthcareguru
healthcareguru Mar. 19 at 1:56 PM
$HTFL nonsense move…going back <$20…lots of PE secondaries coming after lackluster print and slowing growth ahead; insanity valuation.👎 $XLV $IHI $IWM
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 18 at 9:24 PM
$HTFL Q4 '25 Earnings Results & Recap Heartflow reported 2025 revenue of $176M, a 40% increase from 2024, driven by a 47% rise in revenue case volume, achieving a 77% gross margin and a $116.8M net loss.
0 · Reply
topstockalerts
topstockalerts Mar. 18 at 7:02 PM
$HTFL very thin and not widely followed. Moves can be sharp but inconsistent.
0 · Reply
Iggymed
Iggymed Mar. 18 at 4:23 PM
$HTFL debating - is this one of those sell the hype before the news moments or do we think that they will beat earnings this evening and that it will pay off to hold?
2 · Reply
Ernzl123
Ernzl123 Mar. 13 at 12:27 PM
$HTFL wake tf up or you are gonna get dumped .
0 · Reply
Thr0winDarts
Thr0winDarts Mar. 6 at 5:42 PM
$HTFL down 9% the day after I buy. I timed the top perfect!
0 · Reply
Thr0winDarts
Thr0winDarts Mar. 5 at 8:55 PM
$HTFL I bought this today so expect it to drop as is customary with my timing
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 3 at 9:59 PM
$HTFL RSI: 40.45, MACD: -1.6800 Vol: 2.46, MA20: 24.75, MA50: 28.88 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 2 at 11:50 AM
$HTFL
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 27 at 11:59 AM
$HTFL Current Stock Price: $24.10 Contracts to trade: $25.0 HTFL Mar 20 2026 Call Entry: $1.98 Exit: $3.61 ROI: 82% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 24 at 7:49 PM
$HTFL shows a 1D recovery following Aetna coverage news despite a bearish 1W. RSI is neutral, but watch 4H STOCH for entry signals as the AI medical tech sector gains traction before earnings. @DailyAnalysis
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 23 at 7:58 PM
$HTFL shows a 1D recovery following Aetna coverage news despite a bearish 1W. RSI is neutral, but watch 4H STOCH for entry signals as the AI medical tech sector gains traction before earnings. @DailyAnalysis
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 22 at 6:14 PM
$HTFL shows a 1D recovery following Aetna coverage news despite a bearish 1W. RSI is neutral, but watch 4H STOCH for entry signals as the AI medical tech sector gains traction before earnings. @DailyAnalysis
0 · Reply